Press Release :

Bardy Diagnostics Carnation Ambulatory Monitor Patch decreases both time to diagnosis and readmissions in Emergency Department patients with possible arrhythmia concerns in Clinical Study from Overlake Medical Center

BELLEVUE, WA — July 29, 2021– A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation Ambulatory Monitor (CAM) patch was presented at the 2021 Heart Rhythm Society (HRS) Conference. The abstract, “Accelerating Proper Evaluation of Emergency Department Patients for Arrhythmia Concerns with Discharge Use of ECG Patch Monitors,” authored by Marie Yabut, Sarahi Gomes-Duarte, MA., and Eric Shipley, MD, MBA., explores the role of the CAM ECG monitor as a solution for outpatient evaluation after presenting symptoms of cardiac arrhythmias with an inconclusive diagnosis in the emergency department. The decision to either admit or discharge patients for outpatient evaluation is typically arbitrary and there are few alternatives. The abstract concludes that emergency department adoption of ECG monitoring provided an alternative to hospital admission while providing a diagnosis 3 times sooner than average and dramatically reducing return visits to the emergency department.

By utilizing the CAM patch on 412 patients over the 2-year period, the average time of emergency department discharge to diagnosis was 7 days compared to the previous average of 21 days. In addition, emergency department readmissions within 30 days of the initial visit decreased to 7% of study patients compared to readmission of 40% of patients who had the same type of cardiac complaints in the year prior to CAM patch availability.

According to Yabut, using the CAM patch in the emergency department was crucial in providing care for patients with cardiac arrhythmia symptoms occurring outside of normal clinic operating hours. “In the process of this study, we discovered that most patients discharged with the patch occurred outside clinic hours. The availability of the patch in the emergency department benefitted patients who would have otherwise been discharged without a cardiac monitor.” Without application of the CAM patch in the emergency department, patients may experience a substantial waiting period until receiving diagnostic results and proper care.

The study also revealed that using the CAM patch as a point of care solution in the emergency department resulted in new patient referrals to the cardiology/EP department. Between 2018 and 2020, 369 patients were discharged with the CAM patch from the emergency department, and 57 of those patients were then established as cardiac patients. Additionally, 209 patients in the study had no prior cardiology care and were new referrals to Overlake Medical Center’s cardiology/EP department. Due to the diagnostic capabilities of the CAM patch, 178 patients either received further diagnostic testing or a cardiac procedure.

Bardy Diagnostics will be showcasing their CAM patch technology at the 2021 Heart Rhythm Society (HRS) conference in Boston and participating in the conference both virtually and in-person with an exhibitor booth offering visitors an opportunity to explore clinical case studies, experience a new interactive arrhythmia challenge, view a product demo, and discuss clinical issues and trends with the founder of Bardy Diagnostics, Gust H. Bardy, MD. Visit booth #760 at HRS or go to www.bardydx.com/hrs2021.

 

 

Source:

Yabut, M., Gomez-Duarte, S. & Shipley, E. (2021, February 11). Accelerating Proper Evaluation Of Emergency Department Patients For Arrhythmia Concerns With Discharge Use Of ECG Patch Monitors. Overlake Medical Center, Bellevue, WA; cOASIS, The Online Abstract Submission and Invitation System.

About Bardy Diagnostics

Bardy Diagnostics, Inc. is an innovator in digital health and remote patient monitoring, with a focus on providing the most diagnostically accurate and patient-friendly cardiac patch monitors to the industry. The company’s CAM patch is a non-invasive, P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device that is designed to improve patient compliance for adults and children through its lifestyle-enabling form factor. Designed to be worn comfortably and discreetly for up to 14 days, the female-friendly, hourglass-shaped CAM patch is placed on the center of the chest, directly over the heart for optimum ECG signal collection. The proprietary technology of the CAM patch provides optimal detection and clear recording of the often difficult-to-detect P-wave, the signal of the ECG waveform that is essential for accurate arrhythmia diagnosis. For more information, please visit www.bardydx.com.

 

About Overlake Medical Center & Clinics

Overlake Medical Center & Clinics is a nonprofit regional healthcare system based in Bellevue serving the Eastside community since 1960. The health system includes a 349-bed hospital and a growing network of primary, urgent and specialty care clinics located throughout the region. Overlake is recognized locally and nationally for quality and safety, including recurring Leapfrog A ratings and Healthgrades’ Patient Safety Excellence Award in 2019 and 2020. Overlake offers comprehensive advanced services including a dedicated Cancer Center, Level lll Trauma Center, Childbirth Center and Level lll NICU, cardiac, neurosciences, orthopedic and mental health services. As part of Overlake’s commitment to deliver high-quality care and exceptional patient experience for the Eastside community, Overlake collaborates with EvergreenHealth in cardiac services, neurosciences and quality, and with Seattle Cancer Alliance for cancer services. Overlake employs more than 3,000 and is dedicated to its mission of compassionate care for every life it touches. Overlake provided nearly $48 million in charity care over the last three years and is committed to providing exceptional patient care and services. For more information, visit overlakehospital.org.

 

About Heart Rhythm 2021

The Heart Rhythm Society’s annual meeting attracts more than 6,000 of the world’s finest clinicians, scientists, researchers, and innovators in the field of cardiac pacing and electrophysiology. Heart Rhythm 2021 attendees were able to determine how to participate – virtually or in-person. More than 600 international experts in the field will serve as faculty for programing that includes Daily Plenary Sessions, Late-Breaking Clinical Trials, Recorded Cases, Debates, Rhythm Theater Presentations and more, while over 100 exhibitors will showcase innovative products and services.

 

Related Links

PRNewswire

Press Release :

Professor Gust H. Bardy, M.D. of Bardy Diagnostics® Partners with Arrhythmia Alliance to Increase Patient Awareness of Heart Arrhythmias and Early Detection

(Seattle, WA – November 17, 2020) – Chief Medical Officer of Bardy Diagnostics and Clinical Professor of Medicine University of Washington Professor Gust H. Bardy sat down with Trudie Lobban, MBE, Founder and CEO of Arrhythmia Alliance, a non-profit organization dedicated to improving the diagnosis, treatment, and quality of life for all those affected by arrhythmias, to discuss the intricacies of heart arrhythmias (irregular heart rhythm disorders) and the importance of early detection in a patient-facing educational video series.  The videos, spanning topics including information about arrhythmias, the importance of regular heart monitoring, various devices in the market, and the treatment differences between using a pacemaker, an ICD, or an S-ICD, bring awareness of these often overlooked but potentially deadly heart conditions.

“We are delighted that Professor Bardy has partnered with us in this important educational video series, which will help increase awareness about arrhythmias, detection, and information about available treatments for people with arrhythmias,” said Lobban.

“I’ve treated arrhythmia patients since 1982.  Sometimes arrhythmias are minor. Sometimes they are life-threatening. People over 50 are more likely to have serious arrhythmias, but it can happen in very young people too. It is wise to always pay attention to our hearts as heart problems are a major and common cause of disability and premature death.  We commonly get annual blood tests to check for cholesterol levels or diabetes, but we also should have annual tests of our heart rhythms as well, especially in our older years,” said Professor Bardy.

Arrhythmias affect millions of Americans every year, and the most dangerous arrhythmia, ventricular tachycardia, can cause sudden cardiac death, affecting approximately a half million people annually in the United States[1]. Equally serious is the fact that over 2 million people have known atrial fibrillation[2] and many more have episodic asymptomatic atrial fibrillation.  Atrial fibrillation carries a significant risk of stroke whether the patient has symptoms or not.

Consequently, screening for atrial fibrillation with ambulatory monitors is critical to help avoid stroke and to reduce the associated stroke-related costs that burden the healthcare system.  “That said, there are many disorders that appear to be Atrial Fibrillation but are, in fact, not atrial fibrillation even though they superficially appear to be.  Medical grade monitors with a high specificity for differentiating these various atrial fibrillation-like disorders from true atrial fibrillation is critical.  One should not rely upon commercial monitors in this case.  Moreover, several other serious arrhythmias can coexist with atrial fibrillation.  Discerning the difference between these various atrial arrhythmias requires a medical grade ECG monitor.  Commercial devices often focus on an irregular rhythm and casually presume the diagnosis of atrial fibrillation, unaware of the myriad arrhythmias that can masquerade as atrial fibrillation,” said Professor Bardy.

The problem of cardiac arrhythmias does not merely affect those in middle age or advanced age.  There are an estimated 2 million people living with congenital structural heart disease (CHD) in the United States[3], many of whom are in their 20’s and 30’s. People with CHD often develop arrhythmias as young adults.  Per Professor Bardy, such individuals, as well as those with known underlying heart disease should consider cardiac monitoring.  Those over the age of 60 regardless of health status would probably benefit from a heart rhythm evaluation just as they do other periodic checks of their health, like blood pressure, cholesterol, mammography, glucose, etc.  Lobban and Professor Bardy are working hard to bring public awareness and early detection to save lives and improve quality of lives due to irregular heart rhythm disorders.  To learn more, visit https://www.bardydx.com/about-arrhythmias/ and https://www.heartrhythmalliance.org/aa/us/videos

 

About Gust H. Bardy, M.D.

Dr. Bardy has been a cardiac electrophysiologist since 1983 with research interests in cardiac defibrillator technology, cardiac arrest, ablation, heart failure and atrial fibrillation from both a public health and a technological perspective. He has been a researcher and clinician in the field of sudden death and disabling cardiac rhythm disorders for 38 years with over 400 peer-reviewed publications. Dr. Bardy has also developed technological solutions to patient rhythm related problems with over 280 U.S. patents issued, all of which have been incorporated in cardiac rhythm management technologies in use by many medical device companies. Dr. Bardy’s previous company, Cameron Health, was successfully acquired by Boston Scientific in 2012 for its revolutionary Subcutaneous Implantable Defibrillator (S-ICD) product. In addition to serving Bardy Diagnostics, Dr. Bardy holds a faculty position as Clinical Professor of Medicine, Cardiology at the University of Washington.

 

About Arrhythmia Alliance

ARRHYTHMIA ALLIANCE – Working together to improve the diagnosis, treatment, and quality of life for all those affected by arrhythmias. Arrhythmia Alliance is a coalition of patients, caregivers, patient groups, healthcare professionals and organizations and allied professionals working together to improve the detection, diagnosis, and treatment for all those affected by cardiac arrhythmias. By raising awareness and campaigning for the improved detection and care of heart rhythm disorders, Arrhythmia Alliance aims to extend and improve the lives of the millions around the world that these conditions affect. For more information go to www.heartrhythmalliance.org

 

About Bardy Diagnostics:

Bardy Diagnostics, Inc. is an innovator in digital health and remote patient monitoring, with a focus on providing the most diagnostically accurate and patient-friendly cardiac patch monitors to the industry. The company’s CAM patch is a non-invasive, P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device that is designed to improve patient compliance for adults and children through its lifestyle-enabling form factor. Designed to be worn comfortably and discreetly for up to 14 days, the female-friendly, hourglass-shaped CAM patch is placed on the center of the chest, directly over the heart for optimum ECG signal collection. The proprietary technology of the CAM patch provides optimal detection and clear recording of the often difficult-to-detect P-wave, the signal of the ECG waveform that is essential for accurate arrhythmia diagnosis. For more information, please visit www.bardydx.com.

 

[1] https://www.heart.org/en/health-topics/heart-attack/about-heart-attacks/heart-attack-or-sudden-cardiac-arrest-how-are-they-different

[2] https://www.heart.org/en/health-topics/atrial-fibrillation/what-is-atrial-fibrillation-afib-or-af

[3] https://www.cdc.gov/ncbddd/heartdefects/data.html